|Print Page | Close Window|
|September 27, 2016 - 4:06 p.m.|
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis Collaboration
|September 21, 2016 - 5:01 p.m.|
Gilead Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerative Colitis
|There are currently no events scheduled.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.